(Circulation. 1998;98:1881-1885.)
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports |
T Missense Mutation in the Plasma Platelet-Activating Factor Acetylhydrolase Gene With Genetic Susceptibility to Nonfamilial Dilated Cardiomyopathy in Japanese
From the First Department of Internal Medicine (S.I.) and Department of Clinical Laboratory Medicine (M.Y.), Nagoya University School of Medicine, and Department of Geriatric Research (Y.Y.), National Institute for Longevity Sciences, Obu, Aichi, Japan.
Correspondence to Mitsuhiro Yokota, MD, PhD, Department of Clinical Laboratory Medicine, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
BackgroundAlthough several genes or genetic loci that are responsible for or confer susceptibility to familial dilated cardiomyopathy (DCM) have been identified, genetic defects that underlie nonfamilial DCM remain to be characterized. Mice lacking manganese superoxide dismutase exhibit DCM, suggesting that impairment of the defense mechanisms against oxidative stress is an important susceptibility factor for DCM. Plasma platelet-activating factor (PAF) acetylhydrolase also acts as a key defense against oxidative stress by hydrolyzing PAF and oxidized phospholipids. Thus, abnormalities in the activity of this enzyme may result in predisposition to myocardial damage.
Methods and ResultsThe possible association of a
G994 (M allele)
T (m
allele) missense mutation in the plasma PAF acetylhydrolase
gene with genetic susceptibility to nonfamilial DCM has now been
investigated in 122 Japanese individuals with this condition and 226
healthy control subjects. PAF acetylhydrolase activity in plasma was
significantly associated with plasma PAF acetylhydrolase
genotype in both DCM patients and healthy control subjects. The
frequency of the mutant m allele was significantly
higher in DCM patients than in control subjects. Left
ventricular mass (LVM) and the LVM index in DCM patients
with Mm or mm genotypes were
significantly greater than those in patients with the MM
genotype.
ConclusionsThe G994
T mutation in the plasma PAF
acetylhydrolase gene is associated with nonfamilial DCM in Japanese
subjects. Although the mutation is unlikely to be a causative factor,
it may contribute to genetic susceptibility to or progression of
nonfamilial DCM.
Key Words: genes platelets cardiomyopathy
This article has been cited by other articles:
![]() |
P. Richard, E. Villard, P. Charron, and R. Isnard The Genetic Bases of Cardiomyopathies J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A79 - A89. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsutamoto, A. Wada, T. Matsumoto, K. Maeda, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Sawaki, M. Fujii, et al. Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2086 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Charron, F Tesson, O Poirier, V Nicaud, M Peuchmaurd, L Tiret, F Cambien, P Amouyel, O Dubourg, J.-B Bouhour, et al. Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene Eur. Heart J., November 1, 1999; 20(21): 1587 - 1591. [Abstract] [PDF] |
||||
![]() |
C. J. McKenna, S. Ichihara, Y. Yamada, and M. Yokota Familial Dilated Cardiomyopathy • Response Circulation, October 26, 1999; 100 (17): e87 - e87. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |